Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Associations of CD6, TNFRSF1A, and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
[Diagnosis of multiple sclerosis - the 2010 revision of the McDonald criteria.]
Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs.
Early relapses, onset of progression, and late outcome in multiple sclerosis.
Complementary and alternative medicine in multiple sclerosis.
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects with Multiple Sclerosis
Microvesicles: novel biomarkers for neurological disorders.
Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
Managing fatigue in patients with multiple sclerosis.
The little compound that could: how phenytoin changed drug discovery and development.
UVB light attenuates the systemic immune response in CNS autoimmunity.
Santhera enters agreement with Columbia University to investigate additional potential of Catena® in MELAS
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.
Disrupted balance of T cells under natalizumab treatment in multiple sclerosis.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
Multiple sclerosis and oligodendroglioma: an exceptional association.
CHMP assessment report for Sovrima (International nonproprietary name: idebenone)
A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JC virus testing.
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome.
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
Conformational Landscape of N-Glycosylated Peptides Detecting Autoantibodies in Multiple Sclerosis, Revealed by Hamiltonian Replica Exchange.
Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS.

Pages